Image & Video

Vessel-Graph Neural Network Detects Leptomeningeal Collaterals on DSA

First AI to identify individual collateral vessels on DSA with per-vessel scoring

Deep Dive

A team of researchers led by Junyong Cao from the University of Zurich and TU Munich has developed the first AI framework capable of detecting individual leptomeningeal collateral (LMC) vessels directly from digital subtraction angiography (DSA) scans. LMCs are crucial prognostic markers in acute ischemic stroke, but until now automated methods relied on CT angiography (CTA), which cannot resolve individual collaterals. The new vessel-graph neural network approach treats collateral detection as a graph classification problem, where each vessel segment becomes a node in a vascular graph.

The architecture combines a topology-aware graph branch with a dense pixel branch, fusing both in a shared node-probability space. In rigorous five-fold cross-validation, the fused model achieved a PR-AUC of 0.434, significantly outperforming the graph-only (0.403) and pixel-only (0.362) baselines. The graph-pixel fusion allows the model to leverage both structural connectivity and fine-grained image features, enabling precise per-vessel analysis.

This breakthrough moves DSA-based collateral assessment from subjective manual grading (which suffers from poor inter-rater agreement) to objective, AI-driven evaluation. The ability to individualize LMCs opens the door to discovering novel biomarkers and collateral patterns that could improve stroke prognosis and treatment planning. The researchers note this is the first method to enable quantitative, individualized LMC detection on DSA.

Key Points
  • First AI framework to detect individual leptomeningeal collateral vessels on DSA, not just coarse scoring
  • Hybrid graph-pixel architecture achieves PR-AUC of 0.434, outperforming pure graph (0.403) and pixel (0.362) baselines
  • Enables objective, per-vessel quantification of collaterals, replacing subjective manual grading with poor inter-rater reliability

Why It Matters

Enables precise AI-driven collateral assessment in stroke, shifting from subjective grading to objective biomarker discovery.

📬 Get the top 10 AI stories daily